FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA Compliance for Peptide Therapy and BPC 157 Holt Law FDA moves toward easing restrictions on certain peptides BioPharma Dive Bacteriostatic Water for Peptide Reconstitution Australia IM AEGYO BPC 157 Review: Doctor Explains Benefits, Safety & Cancer Risk How to Calculate Peptide Reconstitution Volumes Guide Imperial Peptides UK